🇺🇸 Tango Therapeutics, Inc.
Forum topic · TNGX · Company page: financials, ownership and filings
Join the discussion on Tango Therapeutics, Inc.
Loading…
Results announced on 9 November 2026
Tango Therapeutics, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $68 million.
Insider trading in October 2026
Directors and officers of Tango Therapeutics, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 1 insider sold shares worth about $660,796 in 2 trades.
Awards, option exercises and shares withheld for tax are not counted.
Mutual funds: 205 funds hold $1.3 billion
205 mutual funds in 2 countries hold shares of Tango Therapeutics, Inc. worth $1.3 billion, about 26.2% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 154 funds added shares and 46 sold; on balance they bought $603 million. Share splits are not counted as trading.